✦ LIBER ✦

PDB31 LONG-TERM OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING GLIMEPIRIDE COMBINED WITH LIRAGLUTIDE OR ROSIGLITAZONE

✍ Scribed by R Alfonso; SD Sullivan; C Conner; M Hammer; L Blonde

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB30 IMPROVEMENT IN CARDIOVASCULAR RISK

✍ R Alfonso; SD Sullivan; C Conner; M Hammer; L Blonde 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Patient-reported outcomes in patients wi

✍ Kjeld Hermansen; Ronette L. Kolotkin; Mette Hammer; Milan Zdravkovic; David Matt 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 298 KB

Initial treatment with fixed-dose combin

✍ H. S. Chou; J. P. Palmer; A. R. Jones; B. Waterhouse; C. Ferreira-Cornwell; J. K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Rosiglitazone: Cardiac safety with long-

✍ Alan Salzman; KarenJ. Murphy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

A Simulation of the Comparative Long-ter

✍ Dr. Sean D. Sullivan; Dr. Rafael Alfonso-Cristancho; Dr. Chris Conner; Dr. Mette 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

PDB56 AN ASSESSMENT OF THE LONG-TERM OUT

✍ M Hammer; WJ Valentine; KU Wittrup-Jensen; AJ Palmer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB